A detailed history of Archer Investment Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, Archer Investment Corp holds 15 shares of VXRT stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$9
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Apr 06, 2020

BUY
$1.88 - $5.25 $28 - $78
15 New
15 $0

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $79.7M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.